Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Dopaminergic System in Schizotypal Personality Disorder: Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder

NCT00252044 is registered in ClinicalTrials.gov with Bronx VA Medical Center as lead sponsor.

NCT NCT00252044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Dopaminergic System in Schizotypal Personality Disorder: Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder
Lead sponsor
Bronx VA Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2000
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

other personality disorders, schizotypal personality disorder